View in EDS HTML Full Text PDF Full Text

The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.

Saved in:
Bibliographic Details
Title: The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Authors: Chaccour C; Instituto de Salud Global de Barcelona, Barcelona, Spain. carlos.chaccour@isglobal.org., Ruiz-Castillo P; Instituto de Salud Global de Barcelona, Barcelona, Spain., Richardson MA; Instituto de Salud Global de Barcelona, Barcelona, Spain., Moncunill G; Instituto de Salud Global de Barcelona, Barcelona, Spain., Casellas A; Instituto de Salud Global de Barcelona, Barcelona, Spain., Carmona-Torre F; Instituto de Salud Global de Barcelona, Barcelona, Spain., Giráldez M; Instituto de Salud Global de Barcelona, Barcelona, Spain., Mota JS; Instituto de Salud Global de Barcelona, Barcelona, Spain., Yuste JR; Instituto de Salud Global de Barcelona, Barcelona, Spain., Azanza JR; Instituto de Salud Global de Barcelona, Barcelona, Spain., Fernández M; Instituto de Salud Global de Barcelona, Barcelona, Spain., Reina G; Instituto de Salud Global de Barcelona, Barcelona, Spain., Dobaño C; Instituto de Salud Global de Barcelona, Barcelona, Spain., Brew J; Instituto de Salud Global de Barcelona, Barcelona, Spain., Sadaba B; Instituto de Salud Global de Barcelona, Barcelona, Spain., Hammann F; Instituto de Salud Global de Barcelona, Barcelona, Spain., Rabinovich R; Instituto de Salud Global de Barcelona, Barcelona, Spain.
Source: Trials [Trials] 2020 Jun 08; Vol. 21 (1), pp. 498. Date of Electronic Publication: 2020 Jun 08.
Publication Type: Clinical Trial Protocol; Letter
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32513289
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chaccour+C%22">Chaccour C</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain. carlos.chaccour@isglobal.org.<br /><searchLink fieldCode="AU" term="%22Ruiz-Castillo+P%22">Ruiz-Castillo P</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Richardson+MA%22">Richardson MA</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Moncunill+G%22">Moncunill G</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Casellas+A%22">Casellas A</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Carmona-Torre+F%22">Carmona-Torre F</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Giráldez+M%22">Giráldez M</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mota+JS%22">Mota JS</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Yuste+JR%22">Yuste JR</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Azanza+JR%22">Azanza JR</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Fernández+M%22">Fernández M</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Reina+G%22">Reina G</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Dobaño+C%22">Dobaño C</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Brew+J%22">Brew J</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sadaba+B%22">Sadaba B</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Hammann+F%22">Hammann F</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rabinovich+R%22">Rabinovich R</searchLink>; Instituto de Salud Global de Barcelona, Barcelona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101263253%22">Trials</searchLink> [Trials] 2020 Jun 08; Vol. 21 (1), pp. 498. <i>Date of Electronic Publication: </i>2020 Jun 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial Protocol; Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101263253 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1745-6215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217456215%22">17456215 </searchLink><i>NLM ISO Abbreviation: </i>Trials <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32513289
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13063-020-04421-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 498
    Titles:
      – TitleFull: The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chaccour C
      – PersonEntity:
          Name:
            NameFull: Ruiz-Castillo P
      – PersonEntity:
          Name:
            NameFull: Richardson MA
      – PersonEntity:
          Name:
            NameFull: Moncunill G
      – PersonEntity:
          Name:
            NameFull: Casellas A
      – PersonEntity:
          Name:
            NameFull: Carmona-Torre F
      – PersonEntity:
          Name:
            NameFull: Giráldez M
      – PersonEntity:
          Name:
            NameFull: Mota JS
      – PersonEntity:
          Name:
            NameFull: Yuste JR
      – PersonEntity:
          Name:
            NameFull: Azanza JR
      – PersonEntity:
          Name:
            NameFull: Fernández M
      – PersonEntity:
          Name:
            NameFull: Reina G
      – PersonEntity:
          Name:
            NameFull: Dobaño C
      – PersonEntity:
          Name:
            NameFull: Brew J
      – PersonEntity:
          Name:
            NameFull: Sadaba B
      – PersonEntity:
          Name:
            NameFull: Hammann F
      – PersonEntity:
          Name:
            NameFull: Rabinovich R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 06
              Text: 2020 Jun 08
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1745-6215
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Trials
              Type: main
ResultId 1